Stocks and Investing Stocks and Investing
Tue, January 21, 2020
Fri, January 17, 2020

David Nierengarten Downgraded (SYRS) to Hold and Held Target at $90 on, Jan 17th, 2020


Published on 2024-10-26 20:21:27 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Downgraded "Syros Pharmaceuticals, Inc." (SYRS) to Hold and Held Target at $90 on, Jan 17th, 2020.

David has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Michael King of "JMP Securities" Maintained at Buy with Decreased Target to $160 on, Friday, October 18th, 2019

Contributing Sources